Senhwa Biosciences Inc. has announced that FDA has approved its IND application for basal cell carcinoma (BCC). To accel...
The annual Global Health Forum in Taiwan opened on 28 Oct in Taipei, with Vice President Chen Chien-jen saying that the ...
TWi Biotechnology, Inc. a clinical stage biotechnology company focused on developing novel inhibitors of inflammasomes h...
JHL Biotech announced that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and...
A Memorandum of Understanding (MoU) was recently signed between National Cheng Kung University Hospital and the South In...
ACT Genomics Holdings Company Limited has recently announced the completion of the latest round of equity financing from...
OBI Pharma, Inc., a Taiwan biopharma company, recently announced that the U.S. Food and Drug Administration (FDA) has gr...
Asia's largest biomedical accelerator, H. Spectrum is planning to collaborate with five major companies on a range of in...
Taiwan's Academia Sinica has signed a memorandum of understanding (MoU) with government-backed Development Centre for Bi...
Medytox has said that it has filed a biologics license application with the Taiwan Food and Drug Administration for the ...
JHL Biotech has received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of ...
Japan-based Eisai recently announced that it has entered into an agreement to grant exclusive development and marketing ...
Four brands of drugs made in China that are supposed to lower blood pressure were removed from shelves in Taiwan recentl...
In this digital era, the global health industry is currently undergoing a revolutionary transformation process, and Taiw...
In this rapidly evolving era of health industry transformation, interdisciplinary alliances beyond boundaries will creat...
Taiwan Healthcare+ Expo is the signature expo in Asia Pacific that provides solutions for medicine, health, and care. St...
Belgium-based cancer diagnostics firm Volition has expanded the clinical trial programme of its Nu.Q platform, being dev...
OBI Pharma, a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) has gra...
